Ignite Creation Date:
2025-12-24 @ 5:34 PM
Ignite Modification Date:
2026-01-01 @ 6:50 PM
Study NCT ID:
NCT05482568
Status:
UNKNOWN
Last Update Posted:
2023-10-16
First Post:
2022-07-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Trial of Injectable SHR-A1811 in Combination With Pyrotinib or SHR-1316 in Subjects With Advanced Non-small Cell Lung Cancer
Sponsor:
Jiangsu HengRui Medicine Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-09-15
Start Date Type:
ACTUAL
Primary Completion Date:
2023-11-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-12-30
Completion Date Type:
ESTIMATED
First Submit Date:
2022-07-26
First Submit QC Date:
None
Study First Post Date:
2022-08-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-10-12
Last Update Post Date:
2023-10-16
Last Update Post Date Type:
ACTUAL